BMC Cancer

Celebrating 20 Years of BMC Cancer

New Content Item (1) This year BMC Cancer is celebrating its 20^th Anniversary. Since launching in 2001 we are proud to have become a leading Open Access journal in the oncology field, considering all areas of cancer research from cancer cell biology to epidemiology to cancer therapeutics and much more. We're looking back at our achievements and highlighting some of the most influential research published in the journal over the past two decades.

Last month in BMC Cancer

New in experimental cancer therapeutics: Pre-clinical studies demonstrate that nimotuzumab conjugated to IRDye800CW is safe and does not exhibit toxicities commonly associated with EGFR targeting antibodies

New cancer survivorship study revealed that the use of antidepressants, sedatives and AEDs in patients with low-grad glioma was elevated at 1 year following surgery, compared to matched controls

New in cancer biology: Pilot study suggests that the lack of activation of immune system in the primary tumor might influence the multifactor process of ER+/HER2- breast cancers progression

New in cancer diagnostics: Kiritani et al. present a new rapid diagnostic system with ambient mass spectrometry and machine learning for colorectal liver metastasis

Cutaneous adverse drug reactions (CADR): New study contributes to the mechanistic understanding of the clinically observed CADR during therapy with EGFR inhibitors

New in cancer biology: Merle et al. present the acquisition of cancer stem cell capacities after spontaneous cell fusion

Support and Guidance

Planning to submit a systematic review?

Prof Kelley provides a practical and stepwise approach for systematically reviewing the literature and publishing the results here.

Submitting a study protocol?

Find out more about the journal's criteria and scope for study protocols here.

Are cancer patients better off if they participate in clinical trials?

How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.

Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma

Authors: Xiaoran Li, Chen Xu, Yang Yu, Yan Guo and Hongzan Sun

Content type: Research article

28 July 2021
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients

Authors: Giuliana Cavalloni, Caterina Peraldo-Neia, Annamaria Massa, Carlo Bergamini, Alessandro Trentini, Giovanni De Rosa, Lorenzo Daniele, Fabiola Ciccosanti, Carlo Cervellati, Francesco Leone and Massimo Aglietta

Content type: Research

28 July 2021
Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial

Authors: Angeline Ginzac, Guillaume Dupic, Lucie Brun, Ioana Molnar, Mélanie Casile, Xavier Durando, Pierre Verrelle, Jean-Jacques Lemaire, Toufic Khalil and Julian Biau

Content type: Study protocol

28 July 2021
Cell fusion enhances energy metabolism of mesenchymal tumor hybrid cells to sustain their proliferation and invasion

Authors: Ariadna Brito, Candice Merle, Pauline Lagarde, Benjamin Faustin, Anne Devin, Lydia Lartigue and Frederic Chibon

Content type: Research

28 July 2021
A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer

Authors: Safaa Turkistani, Bruna M. Sugita, Paolo Fadda, Rafael Marchi, Ali Afsari, Tammey Naab, Victor Apprey, Robert L. Copeland Jr, Michael C. Campbell, Luciane R. Cavalli and Yasmine Kanaan

Content type: Research

27 July 2021

Most recent articles RSS

View all articles

An electronic application for rapidly calculating Charlson comorbidity score

Authors: William H Hall, Ramanathan Ramachandran, Samir Narayan, Ashesh B Jani and Srinivasan Vijayakumar

Content type: Software

20 December 2004
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression

Authors: Qing Ji, Xuan Liu, Zhifen Han, Lihong Zhou, Hua Sui, Linlin Yan, Haili Jiang, Jianlin Ren, Jianfeng Cai and Qi Li

Content type: Research article

5 March 2015
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression

Authors: Eira S Roth, David T Fetzer, Bruce J Barron, Usha A Joseph, Isis W Gayed and David Q Wan

Content type: Research article

7 August 2009
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide

Authors: Marie Genin, Francois Clement, Antoine Fattaccioli, Martine Raes and Carine Michiels

Content type: Research article

8 August 2015
Atypical glandular cells in conventional cervical smears: Incidence and follow-up

Authors: René Scheiden, Catherine Wagener, Ulrich Knolle, Walter Dippel and Catherine Capesius

Content type: Research article

19 July 2004

Most accessed articles RSS

View all articles

Featured video: Microparticles, breast cancer's secret weapon?

Your browser needs to have JavaScript enabled to view this video

Read the article

Welcome

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.

Call for submissions: 'Targeted Therapy' Collection

The Editors of BMC Cancer and BMC Medicine invite of submissions to our ‘Targeted Therapy’ cross journal collection. Guest edited by Prof. Min Li (University of Oklahoma Health Sciences Center, USA) and Dr. Yanis Boumber (The Northwestern University, USA).

We advise to submit by 1st August 2021 if you would like your manuscript to be ready for the launch date.

Call for Submissions: 'Microbiome and Cancer' Collection

The Editors of BMC Cancer, BMC Microbiology and Microbiome invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley, Dr. Jacques Ravel and Dr. Sean Devlin.

Open for submissions until 30th September 2021.

BMC Series Focus Issues

July: Open data and data sharing

Data are the cornerstones to transparency and reproducibility of research. At the BMC Series, we offer different article types to help you share your data. Explore some of our open access data publications in this focus issue and browse through the additional reading and resources to learn more about this topic.

June: Water and Sanitation.

In celebration of World Environment Day on the 5^th June, the BMC Series presents a focus issue on Water and Sanitation. We have collated open-access content from across our journals to highlight research into clean water, investigating links between water and health and our overall relationship with water.

BMC Series Blog

Protecting an investment

16 July 2021
Taking care of the patient- not just the disease

14 July 2021
Call for Papers! Introducing BMC Oral Health’s New Collection titled “Teledentistry and Distance Learning: Improving Access to Oral Health Care and Education”

12 July 2021

Editorial: Nobel Prize Cancer Immunotherapy!

Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline